articleTop 1% cited

Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial

JNCI Journal of the National Cancer Institute · 1996 · Vol. 88(13) · pp. 890–899

J.-L. Lefebvre✉(Centre Oscar Lambret)Dominique Chevalier(Hôpital Claude Huriez)B Luboïnski(Institut Gustave Roussy)A. Kirkpatrick(European Organisation for Research and Treatment of Cancer)Laurence Collette(European Organisation for Research and Treatment of Cancer)Tarek Sahmoud(European Organisation for Research and Treatment of Cancer)

View via DOI Publisher page

Abstract

Larynx preservation without jeopardizing survival appears feasible in patients with cancer of the hypopharynx. On the basis of these observations, the EORTC has now accepted the use of induction chemotherapy followed by radiation as the new standard treatment in its future phase III larynx preservation trials.

Head and Neck Cancer Studies Head and Neck Surgical Oncology Salivary Gland Tumors Diagnosis and TreatmentMedicineLaryngectomySurgeryRadiation therapyLarynxInduction chemotherapyCancerChemotherapyNeck dissectionPyriform Sinus

MeSH terms

AdultAgedAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Squamous CellCombined Modality TherapyEuropeFemaleHumansHypopharyngeal NeoplasmsLaryngectomyMaleMiddle AgedPharyngectomyProspective StudiesRadiotherapy Dosage

Citations

1,337

FWCI

52.75

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review